Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Genflow Biosci (GENF) Share Price

Price 0.85p on 05-09-2025 at 18:40:06
Change 0.025p 3.03%
Buy 0.90p
Sell 0.80p
Last Trade: Buy 111,186.00 at 0.851p
Day's Volume: 7,672,128
Last Close: 0.85p
Open: 0.825p
ISIN: GB00BP2C3V08
Day's Range 0.825p - 0.85p
52wk Range: 0.575p - 2.30p
Market Capitalisation: £3.86m
VWAP: 0.839628p
Shares in Issue: 453.55m

Genflow Biosci (GENF) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 111,186 0.851p Ordinary
16:24:37 - 05-Sep-25
Buy* 176,963 0.851p Ordinary
16:22:46 - 05-Sep-25
Buy* 3,667 0.895p Ordinary
15:54:04 - 05-Sep-25
Buy* 1,111 0.895p Ordinary
12:52:58 - 05-Sep-25
Buy* 153 0.895p Ordinary
12:48:17 - 05-Sep-25
Sell* 388 0.80p Ordinary
10:35:39 - 05-Sep-25
Sell* 2,500 0.80p SI Trade
09:46:57 - 05-Sep-25
Buy* 110 0.90p SI Trade
09:46:57 - 05-Sep-25
Sell* 800 0.80p SI Trade
09:46:57 - 05-Sep-25
Sell* 200 0.80p SI Trade
09:46:57 - 05-Sep-25
See more Genflow Biosci trades

Genflow Biosci (GENF) Share Price History

Time period:
to
Date Open High Low Close Volume
5th Sep 2025 (Fri) 0.825 0.85 0.825 0.85 7,672,128
4th Sep 2025 (Thu) 0.825 0.825 0.825 0.825 1,470,312
3rd Sep 2025 (Wed) 0.825 0.825 0.825 0.825 1,607,902
2nd Sep 2025 (Tue) 0.85 0.858 0.80 0.825 12,463,579
1st Sep 2025 (Mon) 0.75 0.85 0.675 0.85 11,244,668
29th Aug 2025 (Fri) 0.75 0.75 0.75 0.75 316,113
28th Aug 2025 (Thu) 0.75 0.75 0.75 0.75 1,433,795
27th Aug 2025 (Wed) 0.65 0.775 0.65 0.75 4,487,810
26th Aug 2025 (Tue) 0.65 0.65 0.65 0.65 4,900,872
25th Aug 2025 (Mon) 0.65 0.65 0.65 0.65 0
22nd Aug 2025 (Fri) 0.65 0.682 0.65 0.65 7,609,614
21st Aug 2025 (Thu) 0.65 0.65 0.575 0.65 10,703,608
20th Aug 2025 (Wed) 0.65 0.65 0.65 0.65 357,856
19th Aug 2025 (Tue) 0.65 0.65 0.65 0.65 2,296,398
18th Aug 2025 (Mon) 0.65 0.62 0.62 0.62 1,291,821
15th Aug 2025 (Fri) 0.625 0.625 0.625 0.625 303,338
14th Aug 2025 (Thu) 0.625 0.664 0.625 0.625 361,787
13th Aug 2025 (Wed) 0.65 0.664 0.664 0.664 2,693,380
12th Aug 2025 (Tue) 0.65 0.65 0.65 0.65 1,219,807
11th Aug 2025 (Mon) 0.675 0.675 0.65 0.65 1,212,982
8th Aug 2025 (Fri) 0.675 0.692 0.675 0.675 711,334
7th Aug 2025 (Thu) 0.675 0.675 0.675 0.675 1,159,813
See more Genflow Biosci price history

Genflow Biosci (GENF) Regulatory News

Date Source Headline
27th Aug 2025 3:07 pm RNS Holding(s) in Company
18th Aug 2025 7:00 am RNS-R Company Update on Dog Trials
24th Jul 2025 7:00 am RNS-R Clinical Readiness Acceleration
17th Jul 2025 7:00 am RNS Genflow Confirms Progression of Grant
17th Jun 2025 7:00 am RNS-R Corporate Update
12th Jun 2025 10:16 am RNS Result of AGM
30th May 2025 3:20 pm RNS Total Voting Rights
28th May 2025 7:00 am RNS-R Genflow Signs Master Services Agreement
22nd May 2025 10:51 am RNS AGM Notice
15th May 2025 7:00 am RNS-R Key SIRT6 Patent Application
See more Genflow Biosci regulatory news

Genflow Biosci (GENF) Share News

EARNINGS AND TRADING: Ondine widens loss as research expenses rise

15th May 2025 14:30

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

IN BRIEF: Genflow Biosciences says investment a vote of confidence

9th May 2025 18:42

Genflow Biosciences PLC - London-based biotechnology firm, which has research facilities in Belgium - raises GBP500,000 via an allotment to Chief Executive Eric Leire of 62.5 million shares at 0.8 pence each. The net proceeds will be used to advance a proof-of-concept trial evaluating the safety and efficacy of its therapeutic candidate in aged dogs, potentially being also a key translational model for age-related conditions in humans. On allotment, Leire agrees to sell these shares at the same price to an already identified purchaser. Leire says: "This investment, without applying any discount, is a strong vote of confidence in our science." He adds: "With this support, we are well-positioned to accelerate our research and bring us closer to delivering impactful solutions to patients." Read More

IN BRIEF: Genflow launches new ophthalmology development programme

10th Apr 2025 14:24

Genflow Biosciences PLC - London-based biotechnology firm, which has research facilities in Belgium - Launches new ophthalmology development programme, focused on advancing a novel gene therapy via its proprietary gene technology. The therapy will use a specially designed non-viral vector engineered for precise delivery of Genflow's SIRT6 to the eye. It is designed to counter ocular problems including several pathologies of the cornea and glaucoma. Read More

Genflow Biosciences enters 2025 with confidence in research progress

6th Jan 2025 14:28

(Alliance News) - Genflow Biosciences PLC on Monday saw shares climb after reporting "significant strides" in its 2024 research programmes. Read More

Genflow Biosciences secures EUR4 million for liver disease treatment

22nd Oct 2024 11:49

(Alliance News) - Genflow Biosciences PLC on Tuesday said it has secured EUR4 million in funding from the Wallonia region in Belgium, to support its gene therapy development work. Read More

See more Genflow Biosci news
FTSE 100 Latest
Value9,208.21
Change-8.66

Login to your account

Forgot Password?

Not Registered